Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0020473 (hyperlipidemia)
 15,891 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Type IB Glycogen storage disease (GSD) is a new variant of type I Glycogen storage disease. It is characterized by same clinical findings: hepatomegaly, fasting hypoglycemia, hyperlipidemia, hyperuricemia, lactic acidosis, renal enlargement, short stature; but it distinguish for normal glucose-6-phosphatase hepatic activity in vitro. The involvement is in G-6-P transport system. Recently has been described in some patients with GSD IB, neutropenia and defective neutrophil mobility. In this report the authors described two family cases of GDS IB that one characterized by severe neutropenia.
 ...
PMID:[Neutropenia in glycogenesis I B]. 659 20

During an 8-months treatment period the effect of Duolip on serum uric acid in 112 patients with hyperlipidemia was studied. In this open clinical trial a long-lasting hypouricemic effect could be shown for Duolip. This response was more pronounced with higher initial serum uric acid concentrations and could only be observed in patients with serum uric acid levels above 6.4 mg%. Thus, in one patient both risk factors of atherosclerosis--hyperlipidemia and hyperuricemia--can be treated by a single drug.
 ...
PMID:[Modification of serum uric acid concentration under long-term therapy with the lipid-regulating drug Duolip]. 662 96

Because of recent heightened epidemiologic interest in persons with very low cholesterol levels, we compared men and women at the lowest and middle deciles of plasma cholesterol in a large population study for multiple sociologic, biologic, and medical attributes. Two sex-specific age groups were studied, 30-54 years and 55-79 years. In general, comparisons between deciles for each of these four age-sex groups revealed only minor differences for demographic variables; systolic or diastolic blood pressure; fasting plasma glucose; weight; height; obesity; cigarette smoking; dietary eggs or milk; medications for hypertension, hyperglycemia, hyperuricemia, or hyperlipidemia; family history of myocardial infarction, diabetes, or stroke; and personal history of myocardial infarction, congestive heart failure, hypertension, or stroke. Thus, the lowest and the middle deciles of plasma cholesterol in this population shared similar sociologic, biologic, and medical profiles. One unexpected finding was somewhat more diabetics in the lowest decile , and greater obesity and triglyceride levels in the lowest decile diabetics compared to either lowest decile non-diabetics or middle decile diabetics, perhaps suggesting a metabolically distinct subset.
 ...
PMID:Characteristics of persons with marked hypocholesterolemia. A population-based study. 671 3

After nearly 10 years in clinical use, prazosin has been shown in numerous studies worldwide to be an effective antihypertensive agent over the entire range of hypertension (mild, moderate, and severe), when used alone or in multitherapy. In addition to its general effectiveness, prazosin is particularly useful in specific subpopulations of hypertensive patients, such as those with impaired renal function, those on hemodialysis, and those with concomitant heart block, bronchospasm, diabetes mellitus, or disturbed carbohydrate metabolism, hyperlipidemia, or hyperuricemia. The side effects of prazosin are usually mild and transient and seldom require discontinuation of the drug. Sexual dysfunction is uncommon. In clinical experience with 22,000 patients receiving an initial dose of 1 mg of prazosin, syncope was reported in 1 of every 667 patients (0.15%). Withholding diuretics for 1 day before initiating prazosin therapy, utilizing prazosin as first-line therapy, limiting the initial dose to 1 mg, and taking it at bedtime are all helpful in eliminating many of the initial adverse effects. Fluid retention, although rare and not as pronounced as that with other antihypertensive agents, may develop on long-term therapy and may necessitate the addition of a diuretic later on.
 ...
PMID:Effectiveness of prazosin as initial antihypertensive therapy. 682 27

Essential hypertension, a disease that affects about 60 million Americans, is not a homogeneous clinical entity. The disease is caused by altered regulation of mechanisms that control arterial pressure. Because the manifestations of the abnormally regulated pressure have many factors, the approaches to treatment likewise may be expected to be multifactorial. Hemodynamic, neural and catecholamine, renopressor, renal excretory and volume, hormonal, electrolyte, and depressor mechanisms are discussed. Associated conditions that must be considered include exogenous obesity, hyperuricemia, coronary artery disease, carbohydrate intolerance, and hyperlipidemia. Clearer understanding of the role of each of these factors in essential hypertension should provide a rationale for wise selection of antihypertensive therapy and allow reversal of the very high rates of cardiovascular morbidity and mortality associated with the disease.
 ...
PMID:Mechanisms contributing to high blood pressure. 684 8

Individuals with type Ia glycogen storage disease (glucose-6-phosphatase deficiency) frequently develop hepatic adenomas. Potential complications involving these adenomas include malignant transformation and hemorrhage. Five of 9 patients with this disease had evidence of hepatic filling defects on radionucleotide liver scan when first evaluated at our hospital. Dietary therapy aimed at preventing hypoglycemia was begun in 7 of the 9 patients. Prevention of hypoglycemia resulted in the correction of all of the metabolic abnormalities (lactic acidosis, hyperlipidemia, hyperuricemia, and growth retardation). Treatment also corrected the marked elevation in plasma glucagon concentrations. A disappearance of the hepatic lesions occurred in 2 of the treated patients, and a marked reduction in size of the adenoma occurred in the third patient. The hepatic filling defects remained present in the two untreated patients. None of the affected patients receiving dietary therapy have developed hepatic adenomas. One of these patients is now 22 yr old and has received dietary therapy for 7 yr. Early dietary therapy seems to be effective in preventing development of adenomas as well as inducing their resolution.
 ...
PMID:Regression of hepatic adenomas in type Ia glycogen storage disease with dietary therapy. 694 8

210 HbA1 percentage tests were determined in 52 ambulatory insulinodependent patients. There was a close correlation between HbA1 and blood-glucose of the previous two months: mean post-prandial, mean daily and, less strongly, mean fasting blood-glucose. The level of glycosylated haemoglobins correlated significantly with blood-glucose of the same time and highly with mean 24 hour glycosuria 0/00 of previous two months. There was also a slight inverse correlation between HbA1 and uricemia. No correlation resulted with total lipemia, serum triglyceride levels, serum total cholesterol levels and HDL cholesterol concentrations. The increased proportions of HbA1 did not not appear to be related to the age of the patients or to the duration of diabetes or to complications. HbA1 measurement is a simple and objective test of metabolic control in diabetic subjects.
 ...
PMID:[Correlations between hemoglobin A1 and other metabolic and clinical parameters in insulin-dependent diabetics followed in ambulatory care]. 711 Jun 4

Victims of atherothrombotic infarction of the brain, the most common variety of stroke, frequently have recurrent strokes. Risk factors believed to accelerate such events include hypertension, diabetes mellitus, hyperlipidemia, atherosclerotic disease (of heart, aortocervical and intracranial vessels), erythrocythemia, stress, tobacco smoking, hyperuricemia, and perhaps obesity. Most prior studies indicate average anticipated 5 year mortality of 35 to 65 percent and stroke recurrence rate of 20 to 40 percent. A consistent effort to control risk factors in 88 survivors of a first cerebral infarction yielded 17 percent mortality and 16 percent stroke recurrence rates during the 5 years following first stroke. This sustained and systematic approach to risk factor management seemed beneficial to these stroke victims.
 ...
PMID:Prevention of recurrent stroke. 730 62

Fifty men with clinically manifest ischemic heart disease (IHD), fifty men with risk indicators of IHD and fifty healthy men were interviewed about experiences of psychological stress in work, family life and education. They were also examined for the presence of hypertension, hyperlipidemia, hyperglycemia, hyperuricemia, obesity, impaired pulmonary function, smoking and alcohol consumption. The relative risk of developing clinical IHD associated with the experience of psychological stress during the five years prior to onset of symptoms was calculated. It was found to be six times greater with than without such experience. This relative risk was not reduced when controlling for conventional risk indicators by means of a multivariate confounder score. When the IHD group was compared to the group with merely risk indicators, the relative risk related to stress was statistically significant, but not when the latter group was compared to the control group. The results indicate that the experience of stress as it is defined in this study may contribute to the development of clinical manifestations of IHD, irrespective of the presence of conventional risk indicators.
 ...
PMID:Impact of psychological stress on ischemic heart disease when controlling for conventional risk indicators. 737 31

Intact arterial vessel wall is not thrombogenic. Disorders of the endothelium in connection with pathological coditions such such as atherosclerosis, hyperlipidaemia, hypertension and hyperuricemia induce interaction of surfaces of high thromboplastic activity with the blood stream. In such situations local formation of thrombin will take place immediately. Evidence is presented for the essential and unique activation of the extrinsic pathway of the plasmatic coagulation system. The local formation of thrombin at pathologically altered arterial wall seems to be an important trigger for arterial thrombosis and haemostasis. It could be that in vivo the initial step of thrombogenesis depends upon the formation of the activator complex between tissue-thromboplastin and factor VII.
 ...
PMID:Thromboplastic activity of human arterial walls and its interaction with the plasmatic coagulation system. 744 Nov 81


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>